Mirtazapine
Product Images NDC 45865-137

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 45865-137). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medsource Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Mirtazapine Str)

Chemical structure diagram of the active ingredient Mirtazapine, showing its molecular configuration with labeled rings and bonds.*

FDA Label Image

Mirtazapine Tablets 15 mg (Pdp 137)

Mirtazapine tablets 15 mg packaging label showing the product as generic for Remeron. The label includes the NDC 45865-0137-30, batch and expiration placeholders, and specifies the tablets are yellow/oblong film-coated and scored. Manufacturer is Rising Health LLC. Directions mention potential dizziness or drowsiness and avoiding alcohol.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.